| Genetic engineering of bacteriophages against infectious diseases Y Chen, H Batra, J Dong, C Chen, VB Rao, P Tao Frontiers in microbiology 10, 954, 2019 | 176 | 2019 |
| Bacteriophage T4 nanoparticles for vaccine delivery against infectious diseases P Tao, J Zhu, M Mahalingam, H Batra, VB Rao Advanced drug delivery reviews 145, 57-72, 2019 | 129 | 2019 |
| Understanding bacteriophage tail fiber interaction with host surface receptor: the key “blueprint” for reprogramming phage host range J Taslem Mourosi, A Awe, W Guo, H Batra, H Ganesh, X Wu, J Zhu International Journal of Molecular Sciences 23 (20), 12146, 2022 | 82 | 2022 |
| COVID-19 vaccines currently under preclinical and clinical studies, and associated antiviral immune response S Jain, H Batra, P Yadav, S Chand Vaccines 8 (4), 649, 2020 | 69 | 2020 |
| A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering J Zhu, N Ananthaswamy, S Jain, H Batra, WC Tang, DA Lewry, ... Science advances 7 (37), eabh1547, 2021 | 55 | 2021 |
| An antibody from single human VH-rearranging mouse neutralizes all SARS-CoV-2 variants through BA.5 by inhibiting membrane fusion S Luo, J Zhang, AJB Kreutzberger, A Eaton, RJ Edwards, C Jing, HQ Dai, ... Science immunology 7 (76), eadd5446, 2022 | 49 | 2022 |
| A bacteriophage-based, highly efficacious, needle-and adjuvant-free, mucosal COVID-19 vaccine J Zhu, S Jain, J Sha, H Batra, N Ananthaswamy, PB Kilgore, EK Hendrix, ... MBio 13 (4), e01822-22, 2022 | 27 | 2022 |
| Design of bacteriophage T4-based artificial viral vectors for human genome remodeling J Zhu, H Batra, N Ananthaswamy, M Mahalingam, P Tao, X Wu, W Guo, ... Nature Communications 14 (1), 2928, 2023 | 25 | 2023 |
| Genetic engineering of bacteriophages against infectious diseases. Front Microbiol 10: 954 Y Chen, H Batra, J Dong, C Chen, VB Rao, P Tao | 16 | 2019 |
| Humanized V (D) J-rearranging and TdT-expressing mouse vaccine models with physiological HIV-1 broadly neutralizing antibody precursors S Luo, C Jing, AY Ye, S Kratochvil, CA Cottrell, JH Koo, ... Proceedings of the National Academy of Sciences 120 (1), e2217883120, 2023 | 13 | 2023 |
| Nucleic acid vaccine platform for dengue and zika flaviviruses J Taslem Mourosi, A Awe, S Jain, H Batra Vaccines 10 (6), 834, 2022 | 11 | 2022 |
| CRISPR engineering of bacteriophage T4 to design vaccines against SARS-CoV-2 and emerging pathogens J Zhu, N Ananthaswamy, S Jain, H Batra, WC Tang, VB Rao Vaccine Design: Methods and Protocols, Volume 1. Vaccines for Human Diseases …, 2022 | 9 | 2022 |
| Engineered bacteriophage t4 nanoparticles as a potential targeted activator of hiv-1 latency in cd4+ human t-cells H BATRA US Patent App. 17/736,181, 2023 | 8 | 2023 |
| Effect of combination antiretroviral therapy on human immunodeficiency virus 1 specific antibody responses in subtype-C infected children S Kumar, H Batra, S Singh, H Chawla, R Singh, S Katpara, AW Hussain, ... Journal of General Virology 101 (12), 1289-1299, 2020 | 6 | 2020 |
| Humanized antibody potently neutralizes all SARS-CoV-2 variants by a novel mechanism S Luo, J Zhang, AJB Kreutzberger, A Eaton, RJ Edwards, C Jing, HQ Dai, ... bioRxiv, 2022.06. 26.497634, 2022 | 3 | 2022 |
| A genetic shift in an escaped transmitted/founder virus guides combinatorial vaccine design against HIV-1 S Jain, G Uritskiy, M Mahalingam, H Batra, S Chand, H Trinh, C Beck, ... bioRxiv, 2021.06. 16.448593, 2021 | 3 | 2021 |
| A Modular Bacteriophage T4 Nanoparticle Platform Enables Rapid Design of Dual COVID‐19‐Flu Mucosal Vaccines J Zhu, J Sha, H Batra, S Jain, X Wu, EK Hendrix, PB Kilgore, K Sun, ... Small Science, 2400580, 2024 | | 2024 |
| A remarkable genetic shift in a transmitted/founder virus broadens antibody responses against HIV-1 S Jain, G Uritskiy, M Mahalingam, H Batra, S Chand, HV Trinh, C Beck, ... Elife 13, RP92379, 2024 | | 2024 |
| Designing Bacteriophage T4 Nanoparticles for HIV Cure H Batra The Catholic University of America, 2020 | | 2020 |